A scoping review of models for predicting the risk of postherpetic neuralgia

对预测带状疱疹后神经痛风险的模型进行范围界定综述

阅读:1

Abstract

OBJECTIVE: To conduct a scoping review of risk prediction models for postherpetic neuralgia (PHN), providing insights for clinical identification of patients at high risk and future research. METHODS: China National Knowledge Infrastructure, Wanfang, VIP Database, Chinese Biomedical Literature Service System (SinoMed), PubMed, Embase, Web of Science and the Cochrane Library databases were systematically searched from database establishment to 25 October 2024, and data on the prevalence of PHN, model construction, predictors and model performance were extracted for summary analysis. RESULTS: A total of 23 studies were included, with a high overall risk of bias. The prevalence of PHN ranged from 6.20 to 48.00%, with traditional logistic regression being the predominant model construction method. The three most frequently identified predictive factors were age, rash area and pain severity score. Additionally, 43.48% of the studies did not validate their models, and 52.17% used visualization methods to present their models. The area under the receiver operator characteristic curve of the studies was 0.714-0.980. Two studies performed external validation; 14 studies evaluated the model's calibration, and the calibration curve coincided well with the actual curve; and eight studies assessed the clinical benefit. CONCLUSION: Risk prediction models for PHN all showed good predictive performance, but the risk of bias was high, and further clinical validation is needed. In the future, research could refine variable selection and model performance evaluation to optimize predictive models continuously, aiming to develop models with excellent predictive performance and strong clinical utility. SYSTEMATIC REVIEW REGISTRATION: DOl: https://doi.org/10.17605/0SF.IO/SUR2C.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。